about
Pharmacologic therapies for adults with acute lung injury and acute respiratory distress syndromeNebulized heparin for patients under mechanical ventilation: an individual patient data meta-analysisSurfactant therapy for acute lung injury and acute respiratory distress syndrome.Clinical effectiveness analysis of dextran 40 plus dexamethasone on the prevention of fat embolism syndrome.Barrier-protective effects of activated protein C in human alveolar epithelial cells.Treatment effects of recombinant human soluble thrombomodulin in patients with severe sepsis: a historical control study.Bench-to-bedside review: the role of glycosaminoglycans in respiratory disease.Coagulopathy as a prognostic factor of acute lung injury in childrenEmerging role of anticoagulants and fibrinolytics in the treatment of acute respiratory distress syndromePharmacotherapy of acute lung injury and acute respiratory distress syndromeNeither fibrin nor plasminogen activator inhibitor-1 deficiency protects lung function in a mouse model of acute lung injuryAcute respiratory distress syndrome: a historical perspective.Nebulized anticoagulants for acute lung injury - a systematic review of preclinical and clinical investigationsBronchoalveolar hemostasis in lung injury and acute respiratory distress syndrome.Impact of thrombosis on pulmonary endothelial injury and repair following sepsis.Stem cells in sepsis and acute lung injuryMesenchymal Stem Cells Overexpressing Angiotensin-Converting Enzyme 2 Rescue Lipopolysaccharide-Induced Lung Injury.Pulmonary net release of tissue-type plasminogen activator during porcine primary and secondary acute lung injury.New insights into the mechanisms of pulmonary edema in acute lung injury.
P2860
Q24246217-CFF62686-25BE-47D8-95EE-B885705FAF55Q26753103-553521AF-4594-4338-B6BE-C46D76DA6D21Q30426177-5E9E3AF3-477B-49C9-ABFA-024CAE0A1491Q34167313-2B4B13F1-7434-46D4-98EF-8A0ABF29EBC2Q34602804-E45FE460-4A5C-4FC8-8344-EB1E29C5A9A1Q35558208-E779531F-0AC2-40E2-8305-BA9BA2A81F9AQ35629808-7B7A202F-0DAD-46C7-83E8-EE94732C143CQ36472995-9059A68B-5A1A-4D6F-B2FC-33B0A600B79DQ36835719-10166BF4-DC1F-4DF3-8D01-F935F00850FCQ37085611-3723B55E-143F-4C2E-A120-20F67F1AAB2FQ37138889-065203B2-A5D2-406A-A0E6-3342A941CC25Q37282570-F21A2D61-3238-4B71-9CF0-5FD089475110Q38006576-6260C8CD-D5FA-4EA1-A325-4BD274BFB764Q38056776-E092408B-311E-431D-8B8A-E0DBAC9B9760Q39107051-E87E68C5-A748-44E4-8A39-B0C95C2AEF0CQ42009420-2392C26C-6E53-41B1-B1F1-1DDBC0D289C0Q45869181-FC2EDA5E-6238-49DB-9347-28D1FFB77340Q47227592-EE9CDB8A-D74F-4EBF-8649-88E2B47A78E5Q49733749-9348FDBD-EED5-4373-9E4F-20F76E0B827A
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Anticoagulant therapy in acute lung injury.
@ast
Anticoagulant therapy in acute lung injury.
@en
type
label
Anticoagulant therapy in acute lung injury.
@ast
Anticoagulant therapy in acute lung injury.
@en
prefLabel
Anticoagulant therapy in acute lung injury.
@ast
Anticoagulant therapy in acute lung injury.
@en
P2093
P1476
Anticoagulant therapy in acute lung injury.
@en
P2093
Jean-François Dhainaut
Pierre-François Laterre
Xavier Wittebole
P304
P356
10.1097/01.CCM.0000057912.71499.A5
P407
P433
P577
2003-04-01T00:00:00Z